REGULATORY ENVIRONMENT FOR MEDICAL DEVICES IN NEW ZEALAND
Journal Title: International Journal of Drug Regulatory Affairs - Year 2017, Vol 5, Issue 1
Abstract
Medical Devices are one of the most important health intervention tools available for the prevention, diagnosis and treatment of diseases and for patient rehabilitation. Although the Medical Devices market in the New Zealand region is very diverse, the existing regulations should be further developed to a greater extent for development of the country’s healthcare sector. Medsafe, the drug and medical device authority of New Zealand has taken steps towards this introducing a web-based online database however, only for the notification of devices in the market which means, there is no premarket assessment for all devices that get sold in the market. The notification process is comparatively very easy and the documentation that is prioritized by Medsafe is only the evidences of the device registration in other countries, like the FDA clearance, the CE certificate or the ARTG listing.
Authors and Affiliations
Akshay Anand M
Keywords
Related Articles
- EP ID EP325751
- DOI 10.22270/ijdra.v5i1.191
- Views 167
- Downloads 0
Scenario of Over the Counter Medicines Worldwide
Over the counter (OTC) drugs are medicines sold directly to consumer without any prescription. The OTC drug market in India is expected to grow by $6.6 billion by 2016 with Pharmaceutical companies and chemists increasin...
ADVANCES IN THE REVIEW OF GENERIC DRUG APPLICATIONS BY UNITED STATES FOOD AND DRUG ADMINISTRATION, A REGULATORY PERSPECTIVE IN THE ERA OF GDUFA (GENERIC DRUG USER FEE AMENDMENT 2012)
A regulatory process, by which a person/organization/sponsor/innovator gets authorization to launch a drug in the market, is known as drug approval process. The United States - Food and Drug Administration (U.S. FDA) has...
Informed Consent form in Clinical Trial
Informed consent form is a vital requirement for research study on the human participant. It is the consent which is given by the subject before participate in clinical trial. Informed consent mainly came in existence af...
A PRAGMATIC WAY TO SUSTAIN IN GENERIC PHARMA ENVIRONMENT: PLCM THROUGH REGULATORY STRATEGIES
Most thoughtful way to sustain in this competitive highly regulated Pharma generic industry environment is depended on understanding the concept of the product life cycle management (PLCM). Fact is a very less number of...
Drug approval process in India and Europe
Every time a new drug is developed it requires a great amount of research work in manufacturing, Pre- clinical Science, Controls, Chemistry & Clinical trials. Regulatory agencies have Drug Reviewers who has the responsib...